Keck J O, Staniunas R J, Coller J A, Barrett R C, Oster M E, Schoetz D J, Roberts P L, Murray J J, Veidenheimer M C
Department of Colon and Rectal Surgery, Lahey Clinic, Burlington, Massachusetts 01805.
Dis Colon Rectum. 1994 Dec;37(12):1271-6. doi: 10.1007/BF02257795.
Successful biofeedback therapy has been reported in the treatment of fecal incontinence and constipation. It is uncertain which groups of incontinent patients benefit from biofeedback, and our impression has been that biofeedback is more successful for incontinence than for constipation.
This study was designed to review the results of biofeedback therapy at the Lahey Clinic.
Biofeedback was performed using an eight-channel, water-perfused manometry system. Patients saw anal canal pressures as a color bar graph on a computer screen. Assessment after biofeedback was by manometry and by telephone interview with an independent researcher.
Fifteen patients (13 women and 2 men) with incontinence underwent a mean of three (range, 1-7) biofeedback sessions. The cause was obstetric (four patients), postsurgical (five patients), and idiopathic (six patients). Complete resolution of symptoms was reported in four patients, considerable improvement in four patients, and some improvement in three patients. Manometry showed a mean increase of 15.3 (range, -3-30) mmHg in resting pressure and 35.7 (range, 13-57) mmHg in squeezing pressure after biofeedback. A successful outcome could not be predicted on the basis of cause, severity of incontinence, or initial manometry. Twelve patients (10 women and 2 men) with constipation underwent a mean of three (range, 1-14) biofeedback sessions. Each had manometric evidence of paradoxic nonrelaxing external sphincter or puborectalis muscle confirmed by defography or electromyography. All patients could be taught to relax their sphincter in response to bearing down. Despite this, only one patient reported resolution of symptoms, three patients had reduced straining, and three patients had some gain in insight.
Biofeedback helped 73 percent of patients with fecal incontinence, and its use should be considered regardless of the cause or severity of incontinence or of results on initial manometry. In contrast, biofeedback directed at correcting paradoxic external sphincter contraction has been disappointing.
已有报道称生物反馈疗法在治疗大便失禁和便秘方面取得了成功。目前尚不确定哪些失禁患者群体能从生物反馈中获益,而且我们的印象是生物反馈对失禁的治疗比对便秘更成功。
本研究旨在回顾拉希诊所生物反馈疗法的治疗结果。
使用八通道水灌注测压系统进行生物反馈治疗。患者在电脑屏幕上以彩色柱状图的形式看到肛管压力。生物反馈治疗后的评估通过测压和由一名独立研究人员进行电话访谈来完成。
15例大便失禁患者(13名女性和2名男性)平均接受了3次(范围1 - 7次)生物反馈治疗。病因包括产科因素(4例患者)、术后因素(5例患者)和特发性因素(6例患者)。4例患者症状完全缓解,4例患者有显著改善,3例患者有一定改善。测压显示生物反馈治疗后静息压力平均升高15.3(范围 - 3 - 30)mmHg,收缩压力平均升高35.7(范围13 - 57)mmHg。无法根据病因、失禁严重程度或初始测压结果预测治疗是否成功。12例便秘患者(10名女性和2名男性)平均接受了3次(范围1 - 14次)生物反馈治疗。每例患者均经排粪造影或肌电图证实存在矛盾性外括约肌或耻骨直肠肌不松弛的测压证据。所有患者都能学会在用力排便时放松括约肌。尽管如此,只有1例患者症状缓解,3例患者排便时用力减少,3例患者有一定的认知改善。
生物反馈疗法对73%的大便失禁患者有帮助,无论失禁的病因、严重程度或初始测压结果如何,都应考虑使用该疗法。相比之下,针对纠正矛盾性外括约肌收缩的生物反馈疗法效果不佳。